Xihua Scientific key facts
as of Oct 2026- Provider of clinical research services created to offer global pharmaceutical companies with high-quality, high-efficiency full-process and integrated services from self-produced drug development to…
- Xihua Scientific is valued at approximately $613.8M as of Oct 2026 (last reported valuation).
- It has raised $199.5M; the latest was PE Growth/Expansion in Feb 2026.
- Notable investors include HSG (Hong Kong), Legend Capital, Highlight Capital, SJ Jiacheng Investment Management, China Merchants Capital — 26 tracked in total.
- Status: Privately Held (backing).
Xihua Scientific's last reported valuation, Mar 2023. Nothing priced has surfaced since.
- ·The complete investor list: 26 names
- ·Watch Xihua Scientific: the Monday email on marks, rounds and moves
Xihua Scientific funding rounds
No funding rounds for Xihua Scientific are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Xihua Scientific
26+Xihua Scientific valuation
Xihua Scientific's last reported valuation was $614 million in Mar 2023. No priced round, secondary trade or fund mark has surfaced since.
Xihua Scientific investors
26 investors are on record for Xihua Scientific, including HSG (Hong Kong), Legend Capital, Highlight Capital and SJ Jiacheng Investment Management.
About Xihua Scientific
Provider of clinical research services created to offer global pharmaceutical companies with high-quality, high-efficiency full-process and integrated services from self-produced drug development to marketing approval. The company provides clinical trial design, laboratory analysis and statistical analysis for pharmaceutical developers, enabling clients to more efficiently bring their new medicine to market.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2015
- Employees
- 657
- Website
- xihuasci.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.